Case Study:  Rapid, Comprehensive Due Diligence for a Mid-Cap Pharma Entering a New Therapy Area

See how a mid-cap pharma company leveraged Omnitheia’s AI and KOL network to validate a late-stage asset in record time, saving on traditional agency markups.